Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease.

MLA

Rocchetti, Maria Teresa, et al. “Urinary Epidermal Growth Factor/Monocyte Chemotactic Peptide 1 Ratio as Non-Invasive Predictor of Mayo Clinic Imaging Classes in Autosomal Dominant Polycystic Kidney Disease.” Journal of Nephrology, vol. 36, no. 4, May 2023, pp. 987–97. EBSCOhost, https://doi.org/10.1007/s40620-022-01468-w.

APA

Rocchetti, M. T., Pesce, F., Matino, S., Piscopo, G., di Bari, I., Trepiccione, F., Capolongo, G., Perniola, M. A., Song, X., Khowaja, S., Haghighi, A., Peters, D., Paolicelli, S., Pontrelli, P., Netti, G. S., Ranieri, E., Capasso, G., Moschetta, M., Pei, Y., & Gesualdo, L. (2023). Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease. Journal of Nephrology, 36(4), 987–997. https://doi.org/10.1007/s40620-022-01468-w

Chicago

Rocchetti, Maria Teresa, Francesco Pesce, Silvia Matino, Giovanni Piscopo, Ighli di Bari, Francesco Trepiccione, Giovanna Capolongo, et al. 2023. “Urinary Epidermal Growth Factor/Monocyte Chemotactic Peptide 1 Ratio as Non-Invasive Predictor of Mayo Clinic Imaging Classes in Autosomal Dominant Polycystic Kidney Disease.” Journal of Nephrology 36 (4): 987–97. doi:10.1007/s40620-022-01468-w.